RCS — Alpha Growth PLC — Result of AGM
For best results when printing this announcement, please click on link below: RNS Number: 9827Y Alpha Growth PLC 14 October 2026 Alpha Growth plc ("Alpha" or the "Company") Result of Annual General Meeting Alpha Growth plc, a leading global specialist in insurance-linked wealth management strategies, and alternative yield solutions, announces that all resolutions proposed at its Annual General Meeting, held 8 October 2026, were duly passed. The following votes were cast at the meeting. For Against 1. To receive the Directors' Report and the Audited Accounts of the 97,873.608 47,666 Company for the year ended 31 March 2026 2. To approve the Directors' Remuneration Report for the year ended 94,743,597 3,180,821 31 March 2026. 3. To authorise the directors to allot equity securities up to an 97,568,908 296,941 aggregate nominal amount of £787,733. 4. To approve the reappointment of Jason Sutherland as a Director. 97,777,477 143,799 5.. To approve the reappointment of Neil Warrender as a Director. 97,777,477 143,799 6. To authorise the Directors to disapply pre-emption rights and 97,768,359 151,674 allot equity securities for cash. 7. To authorise the Directors to make market p
For best results when printing this announcement, please click on link below: RNS Number: 9827Y Alpha Growth PLC 14 October 2026 Alpha Growth plc ("Alpha" or the "Company") Result of Annual General Meeting Alpha Growth plc, ( ) a leading global specialist in insurance-linked wealth management strategies, and alternative yield solutions, announces that all resolutions proposed at its Annual General Meeting, held 8 October 2026, were duly passed. The following votes were cast at the meeting. For Against 1. 608 47,666 Company for the year ended 31 March 2026 2.
To approve the Directors' Remuneration Report for the year ended 94,743,597 3,180,821 31 March 2026. 3. To authorise the directors to allot equity securities up to an 97,568,908 296,941 aggregate nominal amount of £787,733. 4.
To approve the reappointment of Jason Sutherland as a Director. 97,777,477 143,799 5.. To approve the reappointment of Neil Warrender as a Director. 97,777,477 143,799 6.
To authorise the Directors to disapply pre-emption rights and 97,768,359 151,674 allot equity securities for cash. 7. To authorise the Directors to make market purchases of ordinary 97,873,610 47,666 shares of the Company. 8.
To authorise the Directors to call a general meeting, other than 97,868,877 52,399 an AGM, on 14 days' notice. Accordingly, Resolutions 1 — 5 were passed as Ordinary Resolutions, and Resolutions 6 — 8 were passed as Special Resolutions. The Board would like to thank shareholders for their continued support. At the meeting, Neil Warrender in person, Gobind Sahney, Jason Sutherland, by video represented the Directors present to conduct the meeting and took questions from the attending shareholders.
The Directors wish to thank the supportive shareholders who attended the in-person meeting for their attendance and continued support. com). The Company also provides regular updates on RNS Reach. com) UK Investor Relations — Mark Treharne **END** This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange.
Terms and conditions relating to the use and distribution of this information may apply. com) or visit RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy ( ). END NRAMIBBTMTABBBF